Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) -- Traction Uranium Corp. (the “Company” or “Traction”) (CSE: TRAC) (OTC: TRCTF) (FSE: Z1K), a mineral exploration issuer focusing on the...
-
NASHUA, N.H., March 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will be...
-
DUBLIN, Ireland, March 14, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that it will host a...
-
OTTAWA, March 14, 2022 (GLOBE NEWSWIRE) -- Nova Scotia’s construction market is in the midst of a period of sustained growth propelled by major public-sector investments and rising demands for new...
-
GBT Presents its First Two Weeks of Sales WEST HOLLYWOOD, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT” or the “Company”), which entered into a revenue...
-
BURLINGTON, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that it has named industry veteran Marc Montagner as its new Chief...
-
OTTAWA, March 14, 2022 (GLOBE NEWSWIRE) -- New Brunswick’s construction market strengthened in 2021, and should reach a peak in 2022, before receding modestly through 2027. The new labour market...
-
MIAMI, March 14, 2022 (GLOBE NEWSWIRE) -- Klora, a consumer health brand centered around the gut-mind-body connection, announced the launch of its first two products: Bloat-Digest and Gut-Renew. The...
-
GREENVILLE, S.C. and PARIS , March 14, 2022 (GLOBE NEWSWIRE) -- Precision Valve Corporation (“PRECISION” or the “Company”), the aerosol valves world leader and a leading global manufacturer for...
-
- SPEARHEAD-1 met its primary endpoint - planning for afami-cel BLA submission in Q4 2022 for people with synovial sarcoma - - Moving to late-phase development with ADP-A2M4CD8: SURPASS-2 initiated...